Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Schall

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Annals of the Rheumatic Diseases|December 22, 2010
HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupusNicolas Page, Frédéric Gros, Nicolas Schall, et al.
Journal of Autoimmunity|May 1, 2021
Implication of a lysosomal antigen in the pathogenesis of lupus erythematosusMaud Wilhelm, Srinivasa Reddy Bonam, Nicolas Schall, et al.
Frontiers in Pharmacology|November 8, 2021
A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone MiceNicolas Schall, François Daubeuf, Claire Marsol, et al.
Journal of Autoimmunity|June 10, 2018
An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathiesSusana Brun, Nicolas Schall, Srinivasa Reddy Bonam, et al.
Autophagy|February 27, 2015
Modulation of deregulated chaperone-mediated autophagy by a phosphopeptideChristophe Macri, Fengjuan Wang, Inmaculada Tasset, et al.
Arthritis and Rheumatism|November 28, 2008
Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trialSylviane Muller, Fanny Monneaux, Nicolas Schall, et al.
Frontiers in Immunology|February 14, 2017
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting PeptideChristian Maueröder, Nicolas Schall, Frédéric Meyer, et al.
JIMD Reports|November 8, 2024
Clinical experience on switching trientine tetrahydrochloride to trientine dihydrochloride in Wilson disease patientsIsabelle Mohr, Timo Schmitt, Christophe Weber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 3, 2018
Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule OverexpressionMaud Wilhelm, Fengjuan Wang, Nicolas Schall, et al.
Scientific Reports|November 16, 2018
Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survivalFengjuan Wang, Srinivasa Reddy Bonam, Nicolas Schall, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|December 22, 2010
HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupusNicolas Page, Frédéric Gros, Nicolas Schall, et al.
Journal of Autoimmunity|May 1, 2021
Implication of a lysosomal antigen in the pathogenesis of lupus erythematosusMaud Wilhelm, Srinivasa Reddy Bonam, Nicolas Schall, et al.
Frontiers in Pharmacology|November 8, 2021
A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone MiceNicolas Schall, François Daubeuf, Claire Marsol, et al.
Journal of Autoimmunity|June 10, 2018
An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathiesSusana Brun, Nicolas Schall, Srinivasa Reddy Bonam, et al.
Autophagy|February 27, 2015
Modulation of deregulated chaperone-mediated autophagy by a phosphopeptideChristophe Macri, Fengjuan Wang, Inmaculada Tasset, et al.
Arthritis and Rheumatism|November 28, 2008
Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trialSylviane Muller, Fanny Monneaux, Nicolas Schall, et al.
Frontiers in Immunology|February 14, 2017
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting PeptideChristian Maueröder, Nicolas Schall, Frédéric Meyer, et al.
JIMD Reports|November 8, 2024
Clinical experience on switching trientine tetrahydrochloride to trientine dihydrochloride in Wilson disease patientsIsabelle Mohr, Timo Schmitt, Christophe Weber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 3, 2018
Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule OverexpressionMaud Wilhelm, Fengjuan Wang, Nicolas Schall, et al.
Scientific Reports|November 16, 2018
Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survivalFengjuan Wang, Srinivasa Reddy Bonam, Nicolas Schall, et al.
Pageof 3